EASD launches its first ever clinical practice guideline – the world’s first to focus on diabetes distress

The European Association for the Study of Diabetes (EASD) has finalized the draft of its first evidence-based clinical practice guideline. It focuses on the assessment and management of diabetes distress among adults with type 1 diabetes and type 2 diab

2025-09-16

(Press-News.org) Guideline development and inclusiveness

The guideline was developed in line with internationally recognised standards, including the GRADE methodology and the RIGHT reporting statement, and reflects the EASD’s newly established Standard Operating Procedures for guideline development. Importantly, people with lived experience of type 1 diabetes and type 2 diabetes were active members of the Guideline Development Panel from the outset. Their contributions helped shape the clinical questions, interpretation of evidence, and formulation of recommendations, ensuring that the final guideline is firmly grounded in the real-world needs and priorities of adults with diabetes.

Professor Apostolos Tsapas, Aristotle University of Thessaloniki in Greece and Chair of the EASD Guidelines Oversight Committee, said: “The publication of this first EASD guideline is a landmark moment for our Association and for the international diabetes community. Assessing and managing diabetes distress is as vital as assessing and managing glucose levels – and it is this recognition that makes the present guideline so important for both clinical practice and future research to improve the lives of people with diabetes.”

Key recommendations

Recognising the emotional burden of diabetes as a critical component of care, the guideline provides Good Practice Statements for routine assessment of diabetes distress and evidence-based recommendations for its management.

Assessment: Healthcare professionals are encouraged to routinely ask about and assess diabetes distress during consultations. Good Practice Statements recommend discussing the emotional side of diabetes at every appointment, using open-ended questions, and using valid, reliable assessment tools. Regular monitoring is advised as part of the annual cycle of care, with results recorded in clinical notes and discussed openly with the person with diabetes. When distress is identified, healthcare professionals should work together with the individual to agree on next steps, ensuring follow-up support is tailored and person-centred. Management: Evidence-based recommendations support the use of psychological and psychoeducational interventions to reduce diabetes distress, with specific guidance varying according to diabetes type and intervention category. While research gaps remain, the guideline underlines the value of structured support – ranging from psychological therapies to peer support and technology-based interventions – in improving emotional well-being and self-care. A milestone in diabetes care

The launch of this guideline marks a turning point in recognising and addressing the emotional challenges of living with diabetes. Although major advances in treatment and technology have transformed care, many people continue to experience significant emotional and psychological burden in managing the relentless demands of the condition.

Professor Richard Holt, University of Southampton & University Hospital Southampton NHS Foundation Trust in the United Kingdom and Co-Chair of the Guideline Development Panel, said: “We are proud that the EASD has chosen diabetes distress for its first-ever evidence-based clinical guideline. This decision affirms the importance of emotional health alongside physical health for people with diabetes.”

Professor Jane Speight, The Australian Centre for Behavioural Research in Diabetes, Diabetes Victoria and Deakin University in Australia and Co-Chair of the Guideline Development Panel, said: “We hope that this guideline will empower healthcare professionals to routinely assess and address the emotional burden of living with diabetes, ultimately improving outcomes for adults with type 1 and type 2 diabetes across Europe and beyond.”

Professor Chantal Mathieu, Katholieke Universiteit Leuven in Belgium and President of the European Association for the Study of Diabetes, added: “Despite huge advances in therapies and technologies, the emotional burden of diabetes has not diminished – and for many, it has increased. This guideline recognises that reality, reminding us that good diabetes care must address both glucose levels and the lived experience of managing the condition. I am immensely proud to present this first EASD clinical guideline, which reflects the best available evidence and the hard work of many colleagues. It is a milestone in ensuring that emotional well-being becomes a core part of diabetes care.”

Implementation and dissemination

Successful implementation of the guideline will require training, system-level support, and integration into routine care. The EASD plans to support dissemination through peer-reviewed publication, open-access availability, and plain-language summaries designed for accessibility by people living with diabetes and the wider public.

The publication of this first guideline not only addresses an urgent and unmet need in diabetes care but also establishes a framework for future EASD guidelines. The Association is committed to publishing further clinical guidelines, thereby continuing to strengthen the evidence base for person-centred diabetes care.

END

ELSE PRESS RELEASES FROM THIS DATE:

Semaglutide provides powerful protection against diabetic retinopathy, the leading cause of blindness in working-age adults, Greek study suggests

2025-09-16

GLP-1 receptor agonist drugs protect against diabetic retinopathy, a common complication of diabetes that can lead to sight loss, suggests new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15-19 September) and published in the journal Pharmaceutics. GLP-1 drugs such as semaglutide are widely used to treat type 2 diabetes and obesity. They do this by mimicking the action of GLP-1, a hormone that helps the body make more insulin when needed, slows down digestion, curbs appetite and increases feelings of fullness. Many tissues around the body have GLP-1 receptors (proteins ...

Orforglipron taken orally once daily leads to significant body weight loss (ATTAIN-1 Study)

2025-09-16

New research presented at the Annual Meeting of the European Association for the Study of Diabetes in Vienna, Austria (Sept 15-19) and simultaneously published in NEJM shows that daily treatment with the new once-daily GLP-1 agonist orforglipron results in substantial weight loss in people living with obesity that do not have type 2 diabetes. The study is by Dr Sean Wharton, McMaster University, Hamilton, ON, Canada and Wharton Weight Management Clinic, Burlington, ON, Canada, and colleagues. The study is sponsored by Eli Lilly, the manufacturer of orforglipron. Orforglipron is a small-molecule, ...

U of I researchers trace genetic code’s origins to early protein structures

2025-09-16

URBANA, Ill. – Genes are the building blocks of life, and the genetic code provides the instructions for the complex processes that make organisms function. But how and why did it come to be the way it is? A recent study from the University of Illinois Urbana-Champaign sheds new light on the origin and evolution of the genetic code, providing valuable insights for genetic engineering and bioinformatics. “We find the origin of the genetic code mysteriously linked to the dipeptide composition of a proteome, the collective of proteins in an organism,” said corresponding author Gustavo Caetano-Anollés, professor in the Department ...

Disease experts team up with Florida Museum of Natural History to create a forecast for West Nile virus

2025-09-16

Key points State and local officials in Florida maintain hundreds coops with what are referred to as sentinel chickens, which act as an early alarm system for the presence of mosquito-borne illnesses in an area. This alarm system just got an upgrade. An interdisciplinary team of experts, including a zoonotic disease specialist, a museum data scientist and a salamander biologist, have combined their skills and created a statistical model that accurately predicts the activity of West Nile virus in an area up to six months in advance. The model was trained using two decades of sentinel chicken data. The original data files ...

Researchers: Targeted efforts needed to stem fentanyl crisis

2025-09-16

A new study illuminates how some areas of the country have been hit much harder than others by the fentanyl epidemic, which took more than 70,800 lives in 2022 alone. The research calls attention to a need for focused, coordinated efforts to prevent overdose deaths in the places where deaths from the opioid are rampant, said lead author Thomas Wickizer, a professor emeritus in The Ohio State University College of Public Health. The study appears in the journal Health Affairs Scholar. “We can look at this map and see there are certain areas which are experiencing this at an extremely dire rate, and energy and resources, including financial investments, should ...

New UMaine research could help lower prescription drug costs

2025-09-16

One of the main factors driving prices in pharmaceuticals, such as cholesterol-lowering drugs and antibiotics, is the cost of production and materials. Researchers at the University of Maine Forest Bioproducts Research Institute (FBRI) have discovered a sustainable method to produce the key ingredient in a broad range of pharmaceuticals, which could help address high prescription drug costs in the U.S. Among some of the most expensive medications are those that require a chiral center ― a property in which a molecule cannot be superimposed with its mirror image, like right and ...

Molecular movie shows how mitochondria read their DNA

2025-09-16

Aging, neurological diseases and our bodies’ stress response are all linked to the tiny power plants inside each cell known as mitochondria. To function properly, mitochondria must first read instructions from their DNA and then copy it over into mRNA in a process called transcription. Now, researchers at Thomas Jefferson University have reconstructed transcription in human mitochondria in unprecedented detail. The findings, published in Molecular Cell, show how the molecular machinery works and reveal potential drug targets for mitochondrial diseases. “When we understand ...

Loss of key male fertility gene leads to changes in expression of hundreds of other genes

2025-09-16

In a new study conducted at the University of Hawaiʻi at Mānoa, researchers from the John A. Burns School of Medicine (JABSOM) have shown that the loss of a key male fertility gene leads to infertility and changes expression of hundreds of other important genes. The study was led by Professor Dr. Monika Ward from the Department of Anatomy, Biochemistry & Physiology and the Yanagimachi Institute for Biogenesis Research (YIBR). The team has been investigating a zinc finger Y-encoded gene called Zfy. This gene, encoded on Y chromosome in both mice and humans, is considered a male fertility factor. In mice, Zfy is present as two copies, Zfy1 and Zfy2. The researchers ...

Water’s density is key to sustainable lithium mining

2025-09-16

AMHERST, Mass. — One of the biggest obstacles on the road to the low-carbon energy future is caused by the rare-earth element lithium, a critical component for the batteries that can store the abundant and sustainable energy from renewable sources. The element occurs naturally as a salt in briny oases, called salares, in some of the world’s harshest environments, including the “Lithium Triangle” high in South America’s arid Altiplano. Mining lithium has the potential to destabilize already sensitive environments that are host to rare flora and fauna, ...

Pioneering research reveals problem gambling quadruples the risk of suicide among young people four years later

2025-09-16

New research has shown how harmful gambling is clearly linked to a marked and long-lasting increase in suicide attempts among young people in the UK. The study, by researchers at the University of Bristol, found that compared to someone who experiences no gambling harms, problem gamblers face triple the suicide risk one year later, and quadruple the risk four years on. Researchers analysed data from 2,801 people in the renowned Children of the 90s study, which has followed the health and development of 14,000 pregnant women and their families since the early nineties, and which continues ...

LAST 30 PRESS RELEASES:

A hard look at geoengineering reveals global risks

When smoke signals danger: How Australian lizards evolved to escape fire

Beyond the surface: Atopic eczema linked to significantly higher risk of suicidal thoughts, major study finds

After weight loss regular exercise rather than GLP-1 weight-loss drug reduces leading cause of heart attack and strokes